Evidence map›Paper›PMID 40883535›Full record

ArticleAnnals of surgical oncology2025

Noninvasive Prediction of Programmed Cell Death Protein-Ligand 1 Expression in Locally Advanced Non-small Cell Lung Cancer by

Yu Ji, Kai Cui, Juntao Zhang, Jiaqi Wang, Zhengjun Dai, Yong Cui, Haojie Ge, Jingsong Zheng, Dexin Yu

Abstract readMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu JiDepartment of Radiology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
Kai CuiDepartment of Radiology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
Juntao ZhangDepartment of GMS Medical Affairs, GE Healthcare PDX, Shanghai, China.
Jiaqi WangDepartment of Cancer Medical Center, People's Hospital of Chengwu County, Heze, Shandong, China.
Zhengjun DaiDepartment of Scientific Research, Huiying Medical Technology Co., Ltd, Beijing, China.
Yong CuiDepartment of Radiology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
Haojie GeDepartment of AI Innovation, Aspire Information Technologies (Beijing) Limited, Beijing, China.
Jingsong ZhengDepartment of PET/CT, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Dexin YuDepartment of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, China. yudexin0330@sina.com.ORCID http://orcid.org/0000-0002-3430-4817

Funding

Cultivation Foundation of The Second Hospital of Shandong University 2023YP19
6 · The paper itself

Abstract

backgroundProgrammed cell death protein-ligand 1 (PD-L1) expression is an important marker for immunotherapy in locally advanced non-small cell lung cancer (LA-NSCLC). PD-L1 expression has a bi-directional positive feedback relationship with glycolysis status.

objectiveThis study aimed to develop a metabolic habitat model based on

methodsWe included 219 patients from two independent centers and divided them into the training (n = 175) and testing (n = 44) cohorts. Tumors were segmented into four spatially distinct, biologically similar metabolic habitat subregions using the Otsu method. Radiomic characteristics and metabolic parameters were extracted from each habitat and used to generate multiple predictive models based on the Extra Trees classifier. Data from 1043 patients in The Cancer Genome Atlas database were used to analyze the genes associated with PD-L1 expression in NSCLC.

resultsThe metabolic habitat model exhibited the highest performance, with area under the curve values of 0.833 and 0.786 in the training and testing cohorts, respectively, outperforming other models. Subregion analysis revealed that high-glycolytic/high-density habitats (PET

conclusionsThe metabolic habitat model based on

Indexed as

B7-H1 AntigenBiomarkers, TumorCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFluorodeoxyglucose F18Lung NeoplasmsPositron Emission Tomography Computed TomographyAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRadiomicsRadiopharmaceuticalsB7-H1 AntigenBiomarkers, TumorCD274 protein, humanFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTLocally advanced non-small cell lung cancerMetabolic habitat modelPD-L1 expression

Identifiers

PMID40883535
PMCPMC12589310

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.